RxDoctor Payments Data

Tara Elia, MD

Family Practice · Bloomfield Township, MINPI 1497375166

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 42 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by AstraZeneca at 47.8% of the total. Reporting peaked in 2024 at $648 and has fallen 97.6% since, to $16 in 2025. Among family practice clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$738in general payments, 2019–2025

Across 42 payments — averaging $17.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$353
  • Novo Nordisk$150
  • Lilly USA, LLC$125
  • Exact Sciences$55
  • Grifols USA, LLC$25
  • Johnson & Johnson$16
  • plus $16 from 1 others

What the payments were for

  • Food & beverage$738100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$738 in reported general payments places this provider in the 95th percentile of 618 family practice providers in Michigan.

See all family practice providers in Michigan

Medicare billing

Part B allowed, 2024
$18,706
Medicare patients
88
Services billed
377

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide11$17,401
JardianceEmpagliflozin12$12,329
Atorvastatin Calcium49$728
Albuterol Sulfate HfaAlbuterol Sulfate17$618
Losartan Potassium31$425
Metoprolol Succinate21$424
ClopidogrelClopidogrel Bisulfate13$321
Amlodipine Besylate34$254
Levocetirizine Dihydrochloride14$199
Methylprednisolone31$172
Omeprazole14$159
Levothyroxine Sodium14$158
Promethazine Hcl16$144
Azithromycin40$126
Doxycycline Hyclate20$126

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$125$17,40111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 618 family practice providers in Michigan.

Other family practice in Bloomfield Township

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →